Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease (Q45187722)
Jump to navigation
Jump to search
scientific article published on 14 December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease |
scientific article published on 14 December 2004 |
Statements
1 reference
Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease (English)
1 reference
J B Schnog
1 reference
T Teerlink
1 reference
F P L van der Dijs
1 reference
A J Duits
1 reference
F A J Muskiet
1 reference
CURAMA Study Group
1 reference
14 December 2004
1 reference
1 reference
Identifiers
1 reference